Cody J. Peer

Also affiliated with Amgen (United States), Center for Cancer Research

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas

(2023)10.1158/1078-0432.c.6530789

Top 100%

0DataRank

Top 100%0 citations

Ying Yuan, Debra A. Long Priel, Danielle Fink, Cody J. Peer, Tristan M. Sissung +30 more

Papers

Driven by 66 papers — median percentile 0. Top paper: “Selumetinib in Children with Inoperable Plexiform Neurofibromas”.

Selumetinib in Children with Inoperable Plexiform Neurofibromas

New England Journal of Medicine(2020)10.1056/nejmoa1912735

N/A

9.0DataRank · unranked

708 citations

Pamela L. Wolters, Eva Dombi, Andrea Baldwin, Patricia Whitcomb, Michael J. Fisher +24 more

Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma

New England Journal of Medicine(2024)10.1056/nejmoa2401532

N/A

1.5DataRank · unranked

68 citations

Rahul Lakhotia, Stefania Pittaluga, James D. Phelan, Da Wei Huang, George W. Wright +31 more

A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2168

N/A

0.815DataRank · unranked

22 citations

R. Taylor Sundby, Mary Frances Wedekind, Fernanda I. Arnaldez, Jaydira Del Rivero, Lori Wiener +27 more

A Single-arm Phase II Study Combining NLG207, a Nanoparticle Camptothecin, with Enzalutamide in Advanced Metastatic Castration-resistant Prostate Cancer Post-Enzalutamide

The Oncologist(2022)10.1093/oncolo/oyac100

N/A

0.790DataRank · unranked

24 citations

Fatima Karzai, Marijo Bilušić, Lisa M. Cordes, Cindy H. Chau, Cody J. Peer +8 more

Population pharmacokinetic analysis of nanoparticle-bound and free camptothecin after administration of NLG207 in adults with advanced solid tumors

Cancer Chemotherapy and Pharmacology(2020)10.1007/s00280-020-04134-9

N/A

0.730DataRank · unranked

20 citations

Alwin D. R. Huitema, Thomas P. C. Dorlo, Cody J. Peer, Lisa M. Cordes, Linda Sciuto +6 more

Phase 1 study of the immunotoxin LMB‐100 in patients with mesothelioma and other solid tumors expressing mesothelin

Cancer(2020)10.1002/cncr.33145

N/A

0.621DataRank · unranked

62 citations

Christine Alewine, Idrees Mian, Anna Spreafico, Lillian L. Siu, Carlos Gomez‐Roca +13 more

Phase II Randomized Trial of Lenalidomide in Children With Pilocytic Astrocytomas and Optic Pathway Gliomas: A Report From the Children's Oncology Group

Journal of Clinical Oncology(2023)10.1200/jco.22.01777

N/A

0.507DataRank · unranked

10 citations

Gilbert Vézina, Mark Krailo, Linda Springer, Allen Buxton, Cody J. Peer +7 more

Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors

Pediatric Blood & Cancer(2021)10.1002/pbc.29282

N/A

0.461DataRank · unranked

10 citations

Brigitte C. Widemann, Pamela S. Hinds, Rochelle Bagatell, Suzanne Shusterman, Emily Stern +12 more

Metastasis-Specific Gene Expression in Autochthonous and Allograft Mouse Mammary Tumor Models: Stratification and Identification of Targetable Signatures

Molecular Cancer Research(2020)10.1158/1541-7786.mcr-20-0046

N/A

0.457DataRank · unranked

20 citations

Karol Szczepanek, Maxwell Lee, Howard H. Yang, Cody J. Peer, Jessica D. Kindrick +6 more

Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers

Frontiers in Oncology(2024)10.3389/fonc.2024.1386190

N/A

0.421DataRank · unranked

9 citations

Cody J. Peer, Xianyu Zhang, Hyoyoung Choo‐Wosoba, Mehwish Ahmad, Min-Jung Lee +13 more

Biological Effects of Modifications of the Englerin A Glycolate

ACS Medicinal Chemistry Letters(2022)10.1021/acsmedchemlett.2c00258

N/A

0.269DataRank · unranked

5 citations

S. Alice Long, Rhone K. Akee, Gabriela Bermudez, Gregory Parsonage, Jonathan D. Strope +6 more

Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial

Pediatric Blood & Cancer(2025)10.1002/pbc.31584

N/A

0.165DataRank · unranked

2 citations

Eric S. Schafer, Yueh‐Yun Chi, Jemily Malvar, Kenneth Heym, Andrew E. Place +22 more

Bridgehead Modifications of Englerin A Reduce TRPC4 Activity and Intravenous Toxicity but not Cell Growth Inhibition

ACS Medicinal Chemistry Letters(2020)10.1021/acsmedchemlett.0c00186

N/A

0DataRank · unranked

3 citations

Jean‐Simon Suppo, Sarka Tumova, Jonathan D. Strope, Fernando Bravo, Melody Moy +8 more

A phase I trial of pomalidomide in combination with liposomal doxorubicin in patients with Kaposi sarcoma with or without other KSHV-associated diseases.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11552

N/A

0DataRank · unranked

7 citations

Kathryn Lurain, Anaida Widell, Priscila Gonçalves, Irene Ekwede, William D. Figg +9 more

A phase II trial of the DNA methyl transferase inhibitor, SGI-110 (Guadecitabine), in children and adults with SDH-deficient GIST, pheochromocytoma, and paraganglioma, and HLRCC-associated kidney cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11540

N/A

0DataRank · unranked

5 citations

Jaydira Del Rivero, Fernanda I. Arnaldez, Ramaprasad Srinivasan, Melissa Spencer, Seth M. Steinberg +8 more

Phase I study of mesothelin-targeted immunotoxin LMB-100 given as a long infusion with or without nab-paclitaxel.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3553

N/A

0DataRank · unranked

2 citations

Mehwish Ahmad, Yunkai Yu, Akira Yuno, Min-Jung Lee, Cody J. Peer +8 more

Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress

Cancer Cell(2021)10.1016/j.ccell.2021.02.014

N/A

0DataRank · unranked

178 citations

Nobuyuki Takahashi, Vinodh N. Rajapakse, Xiaohu Zhang, Yilun Sun, Michele Ceribelli +36 more

Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics

Science Translational Medicine(2021)10.1126/scitranslmed.abd8077

N/A

0DataRank · unranked

113 citations

Catriona P. Harkins, Nicole H. Schwardt, J. Portillo, NISC Comparative Sequencing Program, Matthew Zimmerman +10 more

Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4730

N/A

0DataRank · unranked

60 citations

Ying Yuan, Debra A. Long Priel, Danielle Fink, Cody J. Peer, Tristan M. Sissung +30 more

Pharmacokinetic Simulation Analysis of Less Frequent Nivolumab and Pembrolizumab Dosing: Pharmacoeconomic Rationale for Dose Deescalation

The Journal of Clinical Pharmacology(2021)10.1002/jcph.1984

N/A

0DataRank · unranked

35 citations

Brian L. Heiss, Daniel A. Goldstein, Jennifer C. Goodell, William D. Figg, Mark J. Ratain +1 more

Development and validation of a simple, selective, and sensitive LC-MS/MS assay for the quantification of remdesivir in human plasma

Journal of Chromatography B(2021)10.1016/j.jchromb.2021.122641

N/A

0DataRank · unranked

34 citations

Jennifer C. Goodell, Priya Shankarappa, Sara Zimmerman, Tyler Yin, Cody J. Peer +2 more

Vertical Inhibition of the RAF–MEK–ERK Cascade Induces Myogenic Differentiation, Apoptosis, and Tumor Regression in H/NRASQ61X Mutant Rhabdomyosarcoma

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0194

N/A

0DataRank · unranked

25 citations

Vanessa Del Pozo, Marielle E. Yohe, Craig M. Goodwin, Terry J. Shackleford, Long Wang +11 more

Adenosine A2A Receptor Activation Enhances Blood–Tumor Barrier Permeability in a Rodent Glioma Model

Molecular Cancer Research(2021)10.1158/1541-7786.mcr-19-0995

N/A

0DataRank · unranked

20 citations

Monica Manglani, DreeAnna Morris, Brandon Foster, Matthew McCord, Hua Song +15 more

Ibrutinib’s off-target mechanism: cause for dose optimization

Cancer Biology & Therapy(2021)10.1080/15384047.2021.1980313

N/A

0DataRank · unranked

13 citations

Cody J. Peer, William D. Figg, Sara Zimmerman

Subcutaneous Atezolizumab: A Jab Without a Benefit

Clinical Pharmacology in Drug Development(2021)10.1002/cpdd.1061

N/A

0DataRank · unranked

4 citations

Sara Zimmerman, William D. Figg, Daniel A. Goldstein, Mark J. Ratain, Cody J. Peer

Phase I study of mesothelin-targeted immunotoxin LMB-100 in combination with tofacitinib in persons with pancreatobiliary cancer or other mesothelin expressing solid tumors.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.tps452

N/A

0DataRank · unranked

5 citations

Mehwish Ahmad, Seth M. Steinberg, Cody J. Peer, William D. Figg, David J. FitzGerald +4 more

Phase I study of mesothelin-targeted immunotoxin LMB-100 in combination with tofacitinib in patients with advanced pancreatobiliary cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.3051

N/A

0DataRank · unranked

4 citations

Mehwish Ahmad, Guillaume Joe Pegna, Cody J. Peer, Jane B. Trepel, Min-Jung Lee +9 more

The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1646

N/A

0DataRank · unranked

21 citations

Xiaolin Wan, Jacob S. Roth, David J. Liewehr, Nancy E. Sealover, William J.E. Frye +29 more

Low serum mesothelin in pancreatic cancer patients results from retention of shed mesothelin in the tumor microenvironment

Translational Oncology(2022)10.1016/j.tranon.2022.101440

N/A

0DataRank · unranked

14 citations

Yunkai Yu, Cody J. Peer, Rebekah Landsman, Nebojša Skorupan, Liang Cao +2 more

Quantitation of the next-generation imipridone ONC206 in human plasma by a simple and sensitive UPLC-MS/MS assay for clinical pharmacokinetic application

Journal of Pharmaceutical and Biomedical Analysis(2022)10.1016/j.jpba.2022.114685

N/A

0DataRank · unranked

7 citations

Sara Zimmerman, Cody J. Peer, Varun V. Prabhu, Tyler Yin, William J. Richardson +7 more

Pharmacokinetics and tolerability of the dual TORC1/2 inhibitor sapanisertib in combination with the MEK inhibitor trametinib in dogs

Frontiers in Veterinary Science(2022)10.3389/fvets.2022.1056408

N/A

0DataRank · unranked

8 citations

Cody J. Peer, William J. Richardson, Stephen M. Hewitt, William D. Figg, R. Mark Simpson +1 more

Cardiac toxicity in a pilot study of duvelisib and ibrutinib combination therapy for chronic lymphocytic leukaemia

British Journal of Haematology(2022)10.1111/bjh.18558

N/A

0DataRank · unranked

2 citations

Douglas R. Rosing, Mark C. Haigney, Cody J. Peer, William D. Figg, Adrian Wiestner +2 more

PARP inhibitors: A review of the pharmacology, pharmacokinetics, and pharmacogenetics

Seminars in Oncology(2023)10.1053/j.seminoncol.2023.09.005

N/A

0DataRank · unranked

83 citations

Oluwatobi Arisa, Cody J. Peer, Antonio Tito Fojo, William D. Figg, Yi Zeng

Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047)

Neuro-Oncology(2023)10.1093/neuonc/noad141

N/A

0DataRank · unranked

64 citations

Tabitha Cooney, John Glod, Jie Huang, Cody J. Peer, Damien Faury +14 more

Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0536

N/A

0DataRank · unranked

38 citations

Nobuyuki Takahashi, Cody J. Peer, Christophe E. Redon, Samantha Nichols, Rasa Vilimas +30 more

Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-0855

N/A

0DataRank · unranked

23 citations

Wei Zhang, Seth M. Steinberg, Darryl Nousome, Nicole Houston, Xiaolin Wu +22 more

In Silico Re‐Optimization of Atezolizumab Dosing Using Population Pharmacokinetic Simulation and Exposure–Response Simulation

The Journal of Clinical Pharmacology(2023)10.1002/jcph.2203

N/A

0DataRank · unranked

14 citations

Keith T. Schmidt, Oluwatobi Arisa, William J. Richardson, Koosha Paydary, Daniel A. Goldstein +4 more

Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma

Cancers(2023)10.3390/cancers15164034

N/A

0DataRank · unranked

13 citations

Adam Cheuk, Kristine A. Isanogle, Christina M. Robinson, Xiaohu Zhang, Michele Ceribelli +22 more

Determination of metarrestin (ML-246) in human plasma for a first-in-human clinical pharmacokinetic application by a simple and efficient uHPLC-MS/MS assay

Journal of Chromatography B(2023)10.1016/j.jchromb.2023.123738

N/A

0DataRank · unranked

2 citations

Sara Zimmerman, Annieka Reno, Natalia Corvalan Cabanas, Oluwatobi Arisa, Rushikesh Sable +3 more

SARC037: Results of phase I study of trabectedin given as a 1-hour (h) infusion in combination with low dose irinotecan in relapsed/refractory Ewing sarcoma (ES).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11519

N/A

0DataRank · unranked

14 citations

Karla V. Ballman, Rachel S. Heise, John Glod, Mary Frances Wedekind, Leo Mascarenhas +15 more

Analysis of systemic immune changes in patients with advanced cancer treated with immunotoxin LMB-100 and tofacitinib.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e15017

N/A

0DataRank · unranked

1 citations

Cody J. Peer, Yunkai Yu, Min-Jung Lee, Sunmin Lee, Shraddha Rastogi +10 more

Data from Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas

(2023)10.1158/1078-0432.c.6530789

Top 100%

0DataRank

Top 100%0 citations

Ying Yuan, Debra A. Long Priel, Danielle Fink, Cody J. Peer, Tristan M. Sissung +30 more

Data from Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas

(2023)10.1158/1078-0432.c.6530789.v1

Top 100%

0DataRank

Top 100%0 citations

Ying Yuan, Debra A. Long Priel, Danielle Fink, Cody J. Peer, Tristan M. Sissung +30 more

Data from Vertical Inhibition of the RAF–MEK–ERK Cascade Induces Myogenic Differentiation, Apoptosis, and Tumor Regression in H/NRASQ61X Mutant Rhabdomyosarcoma

(2023)10.1158/1535-7163.c.6543340.v1

N/A

0DataRank · unranked

0 citations

Vanessa Del Pozo, Marielle E. Yohe, Craig M. Goodwin, Terry J. Shackleford, Long Wang +11 more

Data from Vertical Inhibition of the RAF–MEK–ERK Cascade Induces Myogenic Differentiation, Apoptosis, and Tumor Regression in H/NRASQ61X Mutant Rhabdomyosarcoma

(2023)10.1158/1535-7163.c.6543340

N/A

0DataRank · unranked

0 citations

Vanessa Del Pozo, Marielle E. Yohe, Craig M. Goodwin, Terry J. Shackleford, Long Wang +11 more

Impact of fludarabine exposure on the depth and duration of lymphopenia and CAR T-cell outcomes.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10033

N/A

0DataRank · unranked

0 citations

Bonnie Yates, Nicole Binder, Haneen Shalabi, Cody J. Peer, William D. Figg +3 more

Phase 1/2a study of PRL-02, a long-acting intramuscular (IM) depot injection of abiraterone decanoate, in patients (pts) with advanced prostate cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps5117

N/A

0DataRank · unranked

0 citations

Jose W. Avitia, James L. Bailen, Luke T. Nordquist, William J. Richardson, Cody J. Peer +8 more

Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-24-0225

N/A

0DataRank · unranked

8 citations

Christopher J. Ricketts, Laura S. Schmidt, Julia I. Medina, Keita Saito, Lilia Ileva +25 more

Multi-Component, Time-Course screening to develop combination cancer therapies based on synergistic toxicity

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2413372121

N/A

0DataRank · unranked

8 citations

Frances A. Tosto, Xiaohu Zhang, Christopher Melani, Mark Roschewski, Erin Beck +13 more

Small-molecule disruption of androgen receptor–dependent chromatin clusters

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2406239121

N/A

0DataRank · unranked

4 citations

EK Novak, Subhashish Tapadar, Bocheng Wu, Jonathan D. Strope, Yaw Asante +25 more

Distinct uptake and elimination profiles for trastuzumab, human IgG, and biocytin-TMR in experimental HER2+ brain metastases of breast cancer

Neuro-Oncology(2024)10.1093/neuonc/noae025

N/A

0DataRank · unranked

4 citations

Andy D. Tran, Monika A. Chung, Natalie N. Chung, Brunilde Gril, Christina M. Robinson +8 more

Systemic Treatment with the Janus Kinase Inhibitor Baricitinib in Ocular Chronic Graft-versus-Host Disease

Ophthalmology Science(2024)10.1016/j.xops.2024.100627

N/A

0DataRank · unranked

4 citations

Noa G. Holtzman, Aaron T. Zhao, Chantal Cousineau-Krieger, Susan Vitale, Edmond J. FitzGibbon +11 more

Treatment with novel topoisomerase inhibitors in Ewing sarcoma models reveals heterogeneity of tumor response

Frontiers in Cell and Developmental Biology(2024)10.3389/fcell.2024.1462840

N/A

0DataRank · unranked

0 citations

Ludmila Szabova, Victor J. Collins, Melanie B. Gordon, Kristine Johnson, Deborah B. Householder +15 more

Sustained Interferon Signature Suppression With Anifrolumab in a Patient With STING‐Associated Vasculopathy with Onset in Infancy Refractory to JAK Inhibitor and Dazukibart Therapy

Arthritis & Rheumatology(2025)10.1002/art.43145

N/A

0DataRank · unranked

14 citations

Bjoern Buehring, Adriana A. de Jesus, Sachin Gaurav, Andre Rastegar, Alexi Baumgardner +9 more

Inhibition of p38α MAPK restores neuronal p38γ MAPK and ameliorates synaptic degeneration in a mouse model of DLB/PD

Science Translational Medicine(2023)10.1126/scitranslmed.abq6089

N/A

0DataRank · unranked

40 citations

Changyoun Kim, Somin Kwon, Marcell Szabo, Liam Horan-Portelance, Cody J. Peer +10 more

Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus–associated multicentric Castleman disease

Blood(2020)10.1182/blood.2019004602

N/A

0DataRank · unranked

51 citations

Kathryn Lurain, Cody J. Peer, Anna Serquiña, Victoria Wang, Anaida Widell +10 more

Characterizing the pharmacokinetics of panobinostat in a non-human primate model for the treatment of diffuse intrinsic pontine glioma

Cancer Chemotherapy and Pharmacology(2020)10.1007/s00280-019-04021-y

N/A

0DataRank · unranked

17 citations

Cynthia McCully, Arman Odabas, Rafael Pereira da Cruz, Cody J. Peer, William D. Figg +2 more

Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro

International Journal of Nanomedicine(2020)10.2147/ijn.s234112

N/A

0DataRank · unranked

24 citations

Md. Nazir Hossen, Priya Shankarappa, Cody J. Peer, William D. Figg, J. David Robertson +3 more

Phase 2 Study of Seviteronel (INO-464) in Patients With Metastatic Castration-Resistant Prostate Cancer After Enzalutamide Treatment

Clinical Genitourinary Cancer(2020)10.1016/j.clgc.2019.11.002

N/A

0DataRank · unranked

17 citations

Keith T. Schmidt, Fatima Karzai, Cody J. Peer, Lisa M. Cordes, Cindy H. Chau +8 more

Cerebrospinal fluid penetration of the colony-stimulating factor-1 receptor (CSF-1R) inhibitor, pexidartinib

Cancer Chemotherapy and Pharmacology(2020)10.1007/s00280-020-04071-7

N/A

0DataRank · unranked

14 citations

Cody J. Peer, Arman Odabas, Cynthia Lester McCully, Rafael Cruz Garcia, William D. Figg +2 more

Cabozantinib plus docetaxel and prednisone in metastatic castration‐resistant prostate cancer

British Journal of Urology(2020)10.1111/bju.15227

N/A

0DataRank · unranked

13 citations

Fatima Karzai, Munjid Al Harthy, Daniel P. Petrylak, Joseph W. Kim, Philip M. Arlen +22 more

A phase I trial of lenalidomide and radiotherapy in children with diffuse intrinsic pontine gliomas or high-grade gliomas

Journal of Neuro-Oncology(2020)10.1007/s11060-020-03627-0

N/A

0DataRank · unranked

10 citations

Stewart Goldman, Aradhana Kaushal, Andra Krauze, Deborah E. Citrin, John Glod +17 more

Opportunities for using in silico‐based extended dosing regimens for monoclonal antibody immune checkpoint inhibitors

British Journal of Clinical Pharmacology(2020)10.1111/bcp.14369

N/A

0DataRank · unranked

35 citations

Daniel A. Goldstein, Jennifer C. Goodell, Ryan Nguyen, William D. Figg, Mark J. Ratain +1 more

Efficacy, Tolerability, and Pharmacokinetics of Combined Targeted MEK and Dual mTORC1/2 Inhibition in a Preclinical Model of Mucosal Melanoma

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-19-0858

N/A

0DataRank · unranked

30 citations

Shelley Hoover, Cody J. Peer, Jennifer E. Dwyer, Hibret A. Adissu, Priya Shankarappa +6 more

Case Report: Severe Toxicity in an African–American Patient Receiving FOLFOX Carrying Uncommon Allelic Variants in DPYD

Pharmacogenomics(2020)10.2217/pgs-2020-0120

N/A

0DataRank · unranked

8 citations

Lisa M. Cordes, Cody J. Peer, Shruti U. Gandhy, Jason M. Redman, Julius Strauss +2 more

Plasma and cerebrospinal fluid pharmacokinetics of the DNA methyltransferase inhibitor, 5-azacytidine, alone and with inulin, in nonhuman primate models

Neuro-Oncology Advances(2020)10.1093/noajnl/vdaa005

N/A

0DataRank · unranked

9 citations

Louis Rodgers, Rafael Pereira da Cruz, Marvin L. Thomas, Cody J. Peer, William D. Figg +2 more

Cody J. Peer

Indexed papers

Top data-sharing exemplar

Papers